Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Alexandre

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
Scientific Reports|December 16, 2025
Analysis of anticancer drug associated adverse reactions in depressive patients from vigibaseBasile Chretien, Charles Dolladille, Kazuki Nishida, et al.
Drug Safety - Case Reports|March 31, 2017
Hazardous Drug Diversion of Valproate from a General Practitioner to his Patient's DogPierre-Marie Morice, Joachim Alexandre, Alexandre Cesbron, et al.
Journal of Cardiovascular Pharmacology|October 3, 2013
Dronedarone versus amiodarone in preventing premature ventricular contractions in an in vitro model of "border zone"Joachim Alexandre, René Rouet, Paolo-Emilio Puddu, et al.
Human Psychopharmacology|November 18, 2020
Could N-acetylcysteine improve the safety of clozapine?Basile Chrétien, Sophie Fedrizzi, Véronique Lelong-Boulouard, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|November 13, 2014
Electrophysiological and antiarrhythmic properties of potassium canrenoate during myocardial ischemia-reperfusionJoachim Alexandre, Farzin Beygui, Paolo-Emilio Puddu, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|April 5, 2023
General medicine and notification of adverse reactions: contributions of health insurance representativesSophie Fedrizzi, Basile Chrétien, Marion Sassier, et al.
BMJ Open|November 27, 2025
Association between exposure to proton pump inhibitors and hypertension: a descriptive and disproportionality analysis of VigiBaseBasile Chretien, Matthieu Cacquevel, Nishida Kazuki, et al.
Cells|April 3, 2021
TRPM4 Participates in Aldosterone-Salt-Induced Electrical Atrial Remodeling in MiceChristophe Simard, Virginie Ferchaud, Laurent Sallé, et al.
European Journal of Clinical Pharmacology|January 28, 2015
QT prolongation induced by hydroxyzine: a pharmacovigilance case reportJonathan Vigne, Joachim Alexandre, Fabienne Fobe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 11, 2022
Drug-associated acquired hemophilia A: an analysis based on 185 cases from the WHO pharmacovigilance databaseKonstantin Konstantinov, Charles Dolladille, Benjamin Gillet, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
Scientific Reports|December 16, 2025
Analysis of anticancer drug associated adverse reactions in depressive patients from vigibaseBasile Chretien, Charles Dolladille, Kazuki Nishida, et al.
Drug Safety - Case Reports|March 31, 2017
Hazardous Drug Diversion of Valproate from a General Practitioner to his Patient's DogPierre-Marie Morice, Joachim Alexandre, Alexandre Cesbron, et al.
Journal of Cardiovascular Pharmacology|October 3, 2013
Dronedarone versus amiodarone in preventing premature ventricular contractions in an in vitro model of "border zone"Joachim Alexandre, René Rouet, Paolo-Emilio Puddu, et al.
Human Psychopharmacology|November 18, 2020
Could N-acetylcysteine improve the safety of clozapine?Basile Chrétien, Sophie Fedrizzi, Véronique Lelong-Boulouard, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|November 13, 2014
Electrophysiological and antiarrhythmic properties of potassium canrenoate during myocardial ischemia-reperfusionJoachim Alexandre, Farzin Beygui, Paolo-Emilio Puddu, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|April 5, 2023
General medicine and notification of adverse reactions: contributions of health insurance representativesSophie Fedrizzi, Basile Chrétien, Marion Sassier, et al.
BMJ Open|November 27, 2025
Association between exposure to proton pump inhibitors and hypertension: a descriptive and disproportionality analysis of VigiBaseBasile Chretien, Matthieu Cacquevel, Nishida Kazuki, et al.
Cells|April 3, 2021
TRPM4 Participates in Aldosterone-Salt-Induced Electrical Atrial Remodeling in MiceChristophe Simard, Virginie Ferchaud, Laurent Sallé, et al.
European Journal of Clinical Pharmacology|January 28, 2015
QT prolongation induced by hydroxyzine: a pharmacovigilance case reportJonathan Vigne, Joachim Alexandre, Fabienne Fobe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 11, 2022
Drug-associated acquired hemophilia A: an analysis based on 185 cases from the WHO pharmacovigilance databaseKonstantin Konstantinov, Charles Dolladille, Benjamin Gillet, et al.
Pageof 15